Alexion Pharmaceuticals Inc. (ALXN)

110.42
NASDAQ : Health Technology
Prev Close 112.47
Day Low/High 109.72 / 113.79
52 Wk Low/High 92.56 / 141.86
Avg Volume 1.78M
Exchange NASDAQ
Shares Outstanding 221.29M
Market Cap 24.89B
EPS 0.30
P/E Ratio 7.77
Div & Yield N.A. (N.A)
Sitting Tight for Respectable Volume

Sitting Tight for Respectable Volume

The light volume keeps me hesitant, though here are a few recent standout names.

Bull Market in Biotech

Bull Market in Biotech

The biotechnology sector has weathered the correction and looks ready to push higher.

Fitz Bits: More Quick Bites

Fitz Bits: More Quick Bites

Here's another serving of buy-on-the-bounce trades

Mo-Mos Lose Their Mojo

Mo-Mos Lose Their Mojo

Momentum stocks are under fairly severe pressure.

The Week Ahead: Housing Data, GDP and Earnings

The Week Ahead: Housing Data, GDP and Earnings

Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for the coming week.

Not for the Faint of Heart

Not for the Faint of Heart

The high-fliers I have been showing can reap huge returns, but make sure you can handle the volatility.

Fitz Bits: Stay Long Alexion

Fitz Bits: Stay Long Alexion

The shares are highly likely to test $100. Just keep a trailing stop on any existing positions.

Look for Resting Stocks

Look for Resting Stocks

The virtuous cycle of overrunning price targets is in effect.

Alexion Pharmaceuticals upgraded at UBS

The Cure for Alexion

With only one drug on the market, the pharmaceutical company is expanding its pipeline.

The Day Ahead: Pulling Back

The Day Ahead: Pulling Back

News that Greece will need further austerity measures dragged down world markets and U.S. futures.

Alexion Pharma upgraded at Baird

The Day Ahead: Positioning for 'Jobs Friday'

The Day Ahead: Positioning for 'Jobs Friday'

Stocks were poised for a moderately higher ahead of this highly anticipated monthly event.

Squinting for Playable Stocks

Squinting for Playable Stocks

Despite the massive upsurge, there are still a few interesting setups to consider here.

Searching for a Pulse

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

Scrutinize Those Breakouts

Scrutinize Those Breakouts

Some breakouts, like that of Apple lately, cannot be taken at face value -- especially if they lack volume.

Strong Volume Equals a Strong Foundation

Strong Volume Equals a Strong Foundation

EBIX broke out on Tuesday in heavy volume, which hints at institutional buying in this stock.

Off the Charts

Off the Charts

Keep your risk down at this point as the market still has a lot to prove.

More Safe-Haven Ideas

More Safe-Haven Ideas

Consider this strategy to help protect your portfolio as what could be a very treacherous earnings season approaches.

Biotech Is Booming

Biotech Is Booming

Despite the solid performance so far this year, there's still time to get on board and ride the profit train.

Big-Cap Momentum Names Still Hold Sway

Money is still flowing into some market-moving names, but not into small-caps.  

Fitz Bits: This Calls for Patience

Fitz Bits: This Calls for Patience

Alexion Pharma is too far above established support to be considered a buy at this point, so wait for a pullback closer to this key level.

Three Rock-Solid Names to Watch

Three Rock-Solid Names to Watch

If institutional buyers come into these stocks soon, we could have a nice year-end rally on our hands.

Don't Stay Married to Former Leaders

Don't Stay Married to Former Leaders

Focus on stocks that have come in no more than 30% off their recent highs as they have a good chance of forming sound bases and staging new breakouts.